UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
发明人:
Bellamkonda K. Kishore,Yue Zhang,Carolyn M. Ecelbarger
申请号：
US14438854
公开号：
US10107795B2
申请日:
2013.10.25
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Blunting the activity of the P2Y2 receptor results in a resistance to diet-induced obesity, an increased metabolic rate, and a better glucose tolerance. Compounds that inhibit the puringeric P2Y2 receptor are useful for treating disorders associated with diabetes, treating obesity, and increasing metabolism (e.g., fatty acid metabolism).
